These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Dextran 40,000 in the treatment of shock in myocardial infarct]. Sadowski Z; Giec L; Luczak J; Bielak J Pol Tyg Lek; 1975 Mar; 30(12):519-22. PubMed ID: 1118345 [No Abstract] [Full Text] [Related]
8. Clinical experience with low molecular weight dextran in acute myocardial infarction. Langsjoen PH J Miss State Med Assoc; 1969 Nov; 10(11):499-502. PubMed ID: 5352795 [No Abstract] [Full Text] [Related]
9. [Fast administration of low-molecular dextran to patients with myocardial infarct associated with hypotension and shock]. Gratsianskiĭ NA; Zimin IuV Kardiologiia; 1970 May; 10(5):21-35. PubMed ID: 5448940 [No Abstract] [Full Text] [Related]
10. Low-molecular-weight dextran in acute myocardial infarction. Borchgrevink CF; Enger E Br Med J; 1966 Nov; 2(5524):1235-8. PubMed ID: 5917835 [No Abstract] [Full Text] [Related]
11. OBSERVATIONS IN THE EXCRETION OF LOW MOLECULAR DEXTRAN. LANGSJOEN PH Angiology; 1965 Mar; 16():148-53. PubMed ID: 14258333 [No Abstract] [Full Text] [Related]
12. THE USE OF LOW MOLECULAR WEIGHT DEXTRAN (RHEOMACRODEX) AS AN ANTICOAGULANT IN LEFT ATRIAL TO FEMORAL ARTERY BYPASS. DUBIEL-TOMASZEWSKI W; STERN WR; HALL DP J Thorac Cardiovasc Surg; 1965 Aug; 50():221-8. PubMed ID: 14321521 [No Abstract] [Full Text] [Related]
13. Group II. Acute myocardial infarction treated with low molecular weight dextran. (Lomodex-Tata Fison & Co., ltd). A controled study alongwith some observations on its effects on some laboratory parameters. Lal HB; Caroli RK Indian J Med Res; 1968 Jul; 56(7 Suppl):1116-9. PubMed ID: 4881517 [No Abstract] [Full Text] [Related]
15. [ON THE PROBLEM OF THE HARMFUL ACTION OF A HIGH MOLECULAR DEXTRAN ON BLOOD VESSELS AND MYOCARDIUM OF RABBITS]. BRAUER KH Z Gesamte Inn Med; 1965 Mar; 20():146-8. PubMed ID: 14306474 [No Abstract] [Full Text] [Related]
16. [Treatment of shock in myocardial infarct with dextran and noradrenaline]. Sedziwy L Wiad Lek; 1977 Jan; 30(1):31-5. PubMed ID: 835259 [No Abstract] [Full Text] [Related]
17. [Low-molecular dextran in the treatment of cardiogenic shock]. Dyduszyński A Pol Tyg Lek; 1969 Jul; 24(27):1059-61. PubMed ID: 5805885 [No Abstract] [Full Text] [Related]
18. [Effect of low-molecular dextran on the hemodynamics and activity of serum enzymes in the early periods of myocardial infarction]. Himmel A; Tkaczewski W; Gebicki L Pol Tyg Lek; 1969 Oct; 24(45):1717-20. PubMed ID: 5364152 [No Abstract] [Full Text] [Related]
19. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran. Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157 [No Abstract] [Full Text] [Related]
20. The hemodynamic effect of low molecular weight dextran in arteries with critical stenosis during acute hemorrhage. Christophersen EB; May AG; DeWeese JA; Rob CG Surgery; 1966 Aug; 60(2):402-6. PubMed ID: 5915472 [No Abstract] [Full Text] [Related] [Next] [New Search]